The prescription drug Ozempic was designed to help people with Type 2 diabetes manage their disease, and, under the name Wegovy, to treat obesity. But it has been embraced recently as a tool for weight loss, and many celebrities are rumored to use it in order to shed pounds. Known generically as semaglutide, the drug gives users the feeling of satiation—even to the point of uncomfortable fullness. “One doctor I spoke to compared it to a turkey dinner in a pen,” the staff writer Jia Tolentino tells David Remnick. Tolentino recently reported on the use and misuse of the drug, and what its prominence among celebrities says about our relationship to thinness today. After some years in which body culture seemed to become more accepting, Tolentino fears the drug will wind the clock back to the brutal insistence on thinness of decades past. “Like any technology, it’s very complicated,” she says. “For some people, this drug might save their lives. For others, it does not make sense to be used in any casual way.”
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from The New Yorker Radio Hour
Transcribed and ready to explore now
How the Trump Administration Made Higher Education a Target
17 Oct 2025
The New Yorker Radio Hour
Brian Eno Knows “What Art Does”
03 Jun 2025
The New Yorker Radio Hour
Louisa Thomas on a Ballplayer’s Epic Final Game; Plus, Remembering the Composer of “Annie”
27 May 2025
The New Yorker Radio Hour
Cécile McLorin Salvant Performs Live In-Studio
23 May 2025
The New Yorker Radio Hour
From “On the Media” ’s “Divided Dial”: “Fishing in the Night”
20 May 2025
The New Yorker Radio Hour
Jake Tapper and Alex Thompson on President Joe Biden’s Decline, and Its Cover-Up
16 May 2025
The New Yorker Radio Hour